The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEbiquity Regulatory News (EBQ)

Share Price Information for Ebiquity (EBQ)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 41.00
Bid: 40.00
Ask: 42.00
Change: 0.00 (0.00%)
Spread: 2.00 (5.00%)
Open: 41.00
High: 41.00
Low: 41.00
Prev. Close: 41.00
EBQ Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Statement

27 Jul 2016 07:00

RNS Number : 3058F
Ebiquity PLC
27 July 2016
 

Ebiquity Plc

("the Company")

 

 

Trading Update

 

Ebiquity plc, the leading independent marketing analytics specialists, today announces a trading statement for the half year ended 30 June 2016.

 

Ebiquity continues to grow revenue and profit ahead of the equivalent period last year with overall performance broadly in line with market expectations.

 

The Media Value Measurement practice (MVM) continued to grow in the first half of the year, although we experienced a slow-down in the rate of growth as some contract renewals and new business awards were delayed - particularly in the US - as advertisers awaited the publication of the US Association of National Advertisers' (ANA) Media Transparency reports. We anticipate faster year on year revenue growth over the remainder of the year as advertisers action the ANA's recommendations, prepared in partnership with Ebiquity and FirmDecisions, which were released on 18 July.

 

The Marketing Performance Optimization practice (MPO) has generated significant growth across all markets and achieved record growth overall. We expect strong performance from this practice over the remainder of the year.

 

The Market Intelligence practice (MI), as previously reported, operates in a highly competitive environment with revenues for this business anticipated to decline. Revenue from our platform business (Portfolio) was broadly flat year on year outside the US where revenue reflected pressure on client budgets. Our project based business further contracted as expected although at a faster rate than planned. We are continuing to progress our product development and previews of our upcoming product launches have been well received by clients. These product enhancements should be available for the 2017 renewal season.

 

With approximately two-thirds of Group revenue denominated in non-Sterling currencies, we have received some revenue benefit from Sterling's weakness in the first half of the year. Should this continue, there will be further revenue benefit in the second half of the year, accompanied by a proportionate increase in costs and an overall neutral impact on operating margins.

 

The Company is confident of achieving Board expectations for the full year to 31 December 2016 with improved growth in MVM and a strong performance in MPO offsetting the weaker than initially anticipated performance from MI.

 

On 28 September 2016 the Company will release its interim report for the six month period ended 30 June 2016.

27 July 2016

 

Enquiries:

 

Ebiquity plc

Michael Karg (CEO)

Andrew Beach (CFOO)

 

020 7650 9600

 

Instinctif Partners

Matthew Smallwood

Guy Scarborough

 

020 7457 2020

Numis Securities Limited

Nick Westlake (NOMAD)

Toby Adcock (Corporate Broker)

020 7260 1000

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTEASXKADSKEFF
Date   Source Headline
25th Mar 20197:00 amRNSUnaudited Preliminary Results
1st Mar 20192:15 pmRNSTotal Voting Rights
22nd Feb 20193:55 pmRNSIssue of Shares
18th Feb 20197:00 amRNSHolding(s) in Company
12th Feb 20197:00 amRNSPre-close Trading Update
1st Feb 20197:00 amRNSTotal Voting Rights
23rd Jan 20194:50 pmRNSReplacement: Issue of Shares
23rd Jan 20193:25 pmRNSIssue of Shares
14th Jan 20193:35 pmRNSIssue of Shares
3rd Jan 20192:55 pmRNSIssue of Shares
2nd Jan 201911:40 amRNSDirectorate Change
2nd Jan 201911:40 amRNSCompletion of the disposal of the AdIntel division
2nd Jan 20197:00 amRNSTotal Voting Rights
14th Dec 20187:00 amRNSDirectorate Change
5th Dec 20181:45 pmRNSIssue of Shares
22nd Nov 20187:00 amRNSTrading Update
22nd Nov 20187:00 amRNSStatement re CMA final clearance notification
1st Nov 20187:00 amRNSTotal Voting Rights
24th Oct 20182:40 pmRNSIssue of Shares
23rd Oct 20182:05 pmRNSHolding(s) in Company
18th Oct 20184:06 pmRNSIssue of Shares
15th Oct 20187:00 amRNSIssue of Shares
11th Oct 20187:10 amRNSStatement re CMA Provisional Findings
10th Oct 201812:15 pmRNSDirectorate Change
4th Oct 20187:00 amRNSDirector/PDMR Shareholding
2nd Oct 20187:00 amRNSDirectorate Change
1st Oct 20187:00 amRNSTotal Voting Rights
27th Sep 20189:10 amRNSIssue of Shares
25th Sep 20187:00 amRNSDirectorate Change
25th Sep 20187:00 amRNSInterim Results
3rd Aug 20188:51 amRNSDirector/PDMR Shareholding
1st Aug 20187:00 amRNSTotal Voting Rights
27th Jul 20188:59 amRNSHolding(s) in Company
27th Jul 20188:55 amRNSHolding(s) in Company
27th Jul 20187:00 amRNSIssue of Shares and Director/PDMR Shareholdings
24th Jul 20187:00 amRNSInterim Trading Update
20th Jul 20185:00 pmRNSHolding(s) in Company
11th Jul 20183:05 pmRNSAward of options
6th Jul 20183:00 pmRNSIssue of Shares
25th Jun 20187:15 amRNSStatement re CMA Phase 2 referral
15th Jun 20187:00 amRNSPartnership with Snapchat to enhance measurement
13th Jun 20187:05 amRNSStatement re CMA review of disposal
1st Jun 20189:15 amRNSTotal Voting Rights
18th May 201812:20 pmRNSHolding(s) in Company
9th May 201812:11 pmRNSAGM Resolutions Passed
9th May 20187:00 amRNSIssue of Shares
1st May 20181:10 pmRNSHolding(s) in Company
27th Apr 20187:00 amRNSDirector/PDMR Shareholding
13th Apr 20187:00 amRNSAnnual Report
12th Apr 20182:15 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.